FDA applicant
Abbott Vascular-Cardiac Therapies
FDA records 7 decisions for Abbott Vascular-Cardiac Therapies (Temecula, CA) from 2010 to 2012: 6 510(k) clearances and 1 original PMA approval. Most are in product codes LOX (Catheters, Transluminal Coronary Angioplasty…) and DQX (Wire, Guide, Catheter). Its devices cite 8 predicates, 1 of them its own earlier devices. 20 recalls are linked to its devices, 20 Class I.
Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly
How often FDA has decided Abbott Vascular-Cardiac Therapies’s devices, and how often a recall has named them.
FDA decisions per year
1in 2012
2026 so far, outlined.
Recalls per year
17in 2020
Class I Class II/III not classified
Planning a device like Abbott Vascular-Cardiac Therapies’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.
See the 510(k) ReportOther applicant names beginning “Abbott”
FDA records each applicant name separately; these may or may not be the same firm.